In an obese adult with hypertension, how should pulmonary function tests be interpreted and managed?

Pulmonary Function Tests in Obese Patients with Hypertension

In obese adults with hypertension, expect PFTs to show reduced lung volumes (particularly decreased functional residual capacity and expiratory reserve volume) with preserved airflow and diffusion capacity, and you must actively screen for obesity hypoventilation syndrome and obstructive sleep apnea, as these conditions drive pulmonary hypertension and significantly worsen cardiovascular outcomes.

Expected PFT Patterns in Obesity

Obesity causes characteristic respiratory abnormalities even without underlying lung disease 1:

• Reduced lung volumes: Functional residual capacity decreases due to reduced respiratory system compliance from chest wall and abdominal fat mass
• Decreased expiratory reserve volume (ERV): Present in 96% of obese patients, this is the most consistent finding 2
• Preserved spirometry: Airflow (FEV1/FVC ratio) and diffusion capacity (DLCO) typically remain normal in isolated obesity 3
• Increased small airway resistance with altered breathing patterns

The mechanical effects stem from increased weight on the chest wall and thoracic cage, causing shallow, inefficient breathing 4.

Critical Distinctions to Make

Simple Obesity vs. Obesity Hypoventilation Syndrome

Simple obesity 1:

• Hypoxemia greater than expected for age (present in 92.5% of cases 2)
• Normal daytime PaCO2
• Poor lung base expansion causing ventilation-perfusion mismatch

Obesity hypoventilation syndrome 1:

• Resting daytime hypoxemia AND hypercapnia (PaCO2 ≥50 mmHg)
• Impaired central respiratory drive with decreased ventilatory response to CO2
• Nocturnal alveolar hypoventilation
• Risk of pulmonary hypertension and cor pulmonale

Pulmonary Hypertension Risk

Screen aggressively for pulmonary hypertension in obese hypertensive patients 1, 4, 3:

• 50% of severely obese patients show clinical, radiologic, or ECG evidence of pulmonary arterial hypertension 2
• 42.9% of OHS patients have manifest pulmonary hypertension (mean PAP ≥25 mmHg) despite treatment 5
• Pulmonary hypertension associates with worse functional class, quality of life, and physical functioning 5

Echocardiography should be performed when PH is suspected, looking for 3:

• Elevated tricuspid regurgitation velocity
• Right ventricular hypertrophy
• Right atrial enlargement

Essential Additional Testing

Beyond standard PFTs, obtain 3, 6:

1. Arterial blood gases: To distinguish simple obesity from OHS

   • Simple obesity: Low PaO2, normal or low PaCO2
   • OHS: Low PaO2, elevated PaCO2 (≥50 mmHg)

2. Overnight oximetry or polysomnography: 70-80% of obese patients have nocturnal hypoxemia and sleep apnea 7

3. Chest radiograph: May reveal 6:

   • Cardiac chamber enlargement
   • Pulmonary vascular changes suggesting pulmonary hypertension
   • Undiagnosed heart failure

4. ECG: Look for 6:

   • Right axis deviation
   • Right bundle branch block (suggests pulmonary hypertension)
   • Right ventricular hypertrophy

Management Implications

Pulmonary rehabilitation is the ideal setting to address obesity-related respiratory disorders 1, 3:

• Nutritional education and caloric restriction
• Structured exercise training (≥230 minutes weekly moderate activity 8)
• Weight loss targets: Even 5% weight loss improves metabolic parameters 4, 8
• Psychological support

For hypertension management 9:

• Weight loss strategies (lifestyle, pharmacotherapy, or bariatric surgery) directly address the underlying pathophysiology
• GLP-1 receptor agonists provide dual benefits: weight reduction and blood pressure lowering
• ACE inhibitors or ARBs are appropriate first-line agents, especially if albuminuria present

For obesity hypoventilation syndrome 3:

• Noninvasive positive pressure ventilation (NPPV)
• Higher NPPV adherence correlates with lower pulmonary artery pressures 5

Common Pitfalls

1. Assuming normal PFTs exclude significant pathology: Spirometry may be normal despite severe obesity-related complications like pulmonary hypertension or OHS 3

2. Missing obesity hypoventilation syndrome: Always check arterial blood gases if clinical suspicion exists—don't rely on spirometry alone 6

3. Underestimating cardiovascular risk: The combination of obesity, hypertension, and respiratory abnormalities substantially increases risk of heart failure, pulmonary hypertension, and thromboembolic disease 1, 4

4. Failing to screen for sleep apnea: This is extremely common and treatable, yet often overlooked 7